These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12223320)

  • 1. [Is intermittent dobutamine treatment beneficial in patients with dilated cardiomyopathy?].
    Eryol NK; Güven M; Topsakal R; Abaci A; Başar E; Ergin A; Cetin S
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):220-3. PubMed ID: 12223320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of octreotide in dilated cardiomyopathy: an open-label trial in 12 patients.
    Eryol NK; Güven M; Topsakal R; Sungur M; Ozdogru I; Inanç T; Oguzhan A
    Jpn Heart J; 2004 Jul; 45(4):613-21. PubMed ID: 15353872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy.
    Kitaoka H; Takata J; Yabe T; Hitomi N; Furuno T; Doi YL
    Heart; 1999 May; 81(5):523-7. PubMed ID: 10212172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
    Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of myocardial histomorphometric features and left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy.
    Otasević P; Popović ZB; Vasiljević JD; Vidaković R; Pratali L; Vlahović A; Nesković AN
    Eur J Heart Fail; 2005 Jan; 7(1):49-56. PubMed ID: 15642531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
    J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study.
    Paraskevaidis IA; Adamopoulos S; Kremastinos DT
    J Am Coll Cardiol; 2001 May; 37(6):1685-91. PubMed ID: 11345385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy?
    Cohen A; Chauvel C; Benhalima B; Guyon P; Desert I; Valty J
    Angiology; 1997 Sep; 48(9):783-93. PubMed ID: 9313628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Slade M; Carolan S; Vallejo E; Wackers FJ
    Eur Heart J; 2001 May; 22(10):849-56. PubMed ID: 11350094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of low-dose dobutamine echocardiography in idiopathic dilated cardiomyopathy.
    Galrinho A; Soares RM; Branco LM; Timóteo A; Feliciano J; Santana A; Ferreira R; Quininha J
    Rev Port Cardiol; 2005 Dec; 24(12):1491-501. PubMed ID: 16566407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dobutamine stress echocardiography in prediction of dilated cardiomyopathy in patients with allergic myocarditis].
    Sisakian AS
    Klin Med (Mosk); 1999; 77(7):31-3. PubMed ID: 10483161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regional left ventricular function in dilated cardiomyopathy: observation of regional left ventricular wall motion before and during dobutamine administration].
    Kubo M; Yokota Y; Takarada A; Kumaki T; Seo T; Maehashi N; Toh S; Hayakawa M; Inoh T; Fukuzaki H
    J Cardiogr; 1985 Jun; 15(2):387-98. PubMed ID: 4093622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the functional status of heart failure in non ischemic dilated cardiomyopathy: an echo-dobutamine study.
    Paraskevaidis IA; Tsiapras DP; Adamopoulos S; Kremastinos DT
    Cardiovasc Res; 1999 Jul; 43(1):58-66. PubMed ID: 10536690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.